The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy
1 other identifier
interventional
47
1 country
1
Brief Summary
note effect of appropriate nutrition on head and neck cancer patients receiving radiotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
June 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedSeptember 12, 2025
September 1, 2025
2.7 years
March 26, 2024
September 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
nutritional status of patients
Follow up improvement by evaluating weight in kg and height in meters to calculate body mass index in kg / m\^2
two years
Study Arms (2)
control group
NO INTERVENTIONpatients of head and neck cancer receiving radiotherapy , who did not receive any nutritional support during radiotherapy
nutritional support grouped
ACTIVE COMPARATORpatients of head and neck cancer receiving radiotherapy , who receive any nutritional support during radiotherapy whether oral or intravenous like dipeptivine for mucositis
Interventions
note effect with usually prescribed suitable oral and parenteral nutrition for head and neck cancers receiving radiotherapy
Eligibility Criteria
You may qualify if:
- head and neck cancer patients with age \>18
- Newly diagnosed head and neck cancer patients
- histological proven HNC cancer
- head and neck cancer patients treated with radiotherapy or chemo radiotherapy
You may not qualify if:
- Advanced and Metastatic head and neck cancer patients
- head and neck cancer patients treated with chemotherapy only
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Reham mohamed
Asyut, Egypt
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Asmaa Abdehtawab, lecturer
Assiut University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor at oncology department of Assiut university hospital
Study Record Dates
First Submitted
March 26, 2024
First Posted
June 27, 2024
Study Start
January 1, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- will be available after two years and used whenever it needed
- Access Criteria
- at scientific research magazines
when research is publicly puplished